An Increase of Adropin Can Predict Depression Improvement

TL;DR

This study suggests that increased adropin levels may be linked to improvement in depression symptoms over time.

Contribution

The study introduces adropin as a potential biomarker for depression treatment response.

Findings

Initial adropin levels were not significantly different between depression patients and healthy controls.

Adropin levels increased in depression patients after six months of treatment.

The increase in adropin was associated with potential improvement in depression symptoms.

Abstract

Objectives Depression is characterized by a lack of energy, social withdrawal, and fatigue, and it is also associated with increased inflammation in the brain. Some studies suggest that adropin may have anti-inflammatory effects and could reduce the inflammatory processes contributing to depression. Methods: We included 54 newly diagnosed patients experiencing their first episode of depression and 56 healthy volunteers in this study. The participants with depression were divided into three subgroups based on DSM-5 and BDI-II criteria. The focus of the study was to compare adropin levels between depressive patients and healthy volunteers, as well as to monitor changes in adropin levels after six months of treatment for depressive patients. Results: Initial measurements showed no significant differences in standard laboratory parameters or adropin levels between the depression and control groups. However, adropin and vitamin D levels increased in the group of depressive patients during the six-month follow-up. Conclusions: Our research indicates that adropin plays a significant role in the development of depression and may influence the effectiveness of depression treatments.

Figures